Clinical Trial Update: Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

View source ↗

Summary

This clinical trial investigates one-year dual antiplatelet therapy after GENOSS DES implantation in coronary artery disease patients. The study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• GENOSS DES

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Status: RECRUITING